Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ana Isabel Gil García"'
Autor:
Mar Riveiro-Barciela, Angela Carvalho-Gomes, Ana Barreira, Helena Hernandez-Évole, Francisco Rodriguez-Frias, Rafael Esteban, María García-Eliz, Luisa Roade, Antonio Madejón, Sabela Lens, Sara Sopena, Sergio Rodriguez-Tajes, Ana Isabel Gil-García, Adriana Palom, Javier García-Samaniego, Marina Berenguer-Hayme, Maria Buti
Publikováno v:
Alimentary Pharmacology & Therapeutics. 54:462-469
BACKGROUND Spontaneous HDV-RNA fluctuations, assessed by nonstandardised in-house assays, have been reported during the course of chronic hepatitis delta (CHD). AIMS To evaluate changes in serum HDV-RNA concentrations in untreated CHD patients and co
Autor:
A. López-López, Irene Francisco-Recuero, A. García, Javier García-Samaniego, Rocío Mena, Juan Ramón Larrubia, Antonio Madejón, Emiliana Villafranca, Ana Isabel Gil-García, Miriam Romero, Antonio Olveira
Publikováno v:
World Journal of Gastroenterology
Background Antiviral treatment of patients with chronic hepatitis B (CHB) in the grey zone of treatment comands risk management in order to optimize the health outcome. In this sense, the identification of HBV mutants related with an increased risk o
Autor:
Manuel Román-Martínez, Ana Isabel Gil García, Dolores Ochoa-Mazarro, Francisco Abad-Santos, Ana Ruiz-Nuño, Aneta Wojnicz
Publikováno v:
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
instname
Omeprazole (OME) is a proton pump inhibitor (PPI) with 58% bioavailability after single oral dose, presenting large inter-individual variations and significant drug-drug interactions. A simple and rapid liquid chromatography in tandem with mass spect